IRA Exposure Modeling Guide

This guide explains how market access and finance teams can identify candidate assets, align CMS spending windows, calculate small molecule and biologic clocks, and connect patent or exclusivity context before price negotiation decisions are announced.

Recommended data products

Use CMS IRA Maximum Fair Price Intelligence, Medicare Part D Drug Spending Intelligence, FDA Small Molecule Approval Registry, FDA Approved Biologics Registry, Orange Book patent intelligence, and exclusivity intelligence.

Core model

The most robust model separates statutory eligibility, spend ranking, orphan and biologic exclusions, and lifecycle protection. The Data Developers delivers each input as a typed table so analysts can create scenarios inside BigQuery or Snowflake.